Monitoring of Brain Metabolites Using Proton and Deuterium MR Techniques
A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 140 participants.
Also called NCT06705010
- Study
- In this atlas
Overview
- Design
- Interventional study; non-randomized; single masking; primary purpose basic science
- Phase
- Not applicable
- Enrolled
- 140 participants
- Registry
-
NCT06705010
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Switzerland
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT06705010. Non-randomized; single masking; primary purpose basic science. Start 2025-04-01 (anticipated); primary completion 2026-11-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Monitoring of Brain Metabolites Using Proton and Deuterium MR Techniques
- Acronym
- SIGNATURES2023
- Condition
- Aging
- Condition
- Brain Metabolic Disorder
- Condition
- Carotid Stenosis
- Condition
- Alzheimer Disease
- Condition
- Diabetes Type 2
- Condition
- Mild Cognitive Impairment
- Condition
- Brain Disease
- Intervention (Device)
- Application of new pulse sequence package SIGNATURES2023 to healthy controls
- Intervention (Device)
- Application of new pulse sequence package SIGNATURES2023 to 4 groups of patients (pilot)
- Lead sponsor
- Insel Gruppe AG, University Hospital Bern
Record details
- Record id
cardio:ct-nct06705010- Content hash
06fb1d32626d5d4d2cad3e97dce3f42a706b755f30d3672771687c1635e9986d